Swedbank AB lowered its stake in Darling Ingredients Inc. (NYSE:DAR – Free Report) by 56.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 23,101 shares of the company’s stock after selling 30,419 shares during the quarter. Swedbank AB’s holdings in Darling Ingredients were worth $858,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of DAR. Dimensional Fund Advisors LP lifted its position in Darling Ingredients by 52.4% in the second quarter. Dimensional Fund Advisors LP now owns 5,236,616 shares of the company’s stock valued at $192,445,000 after purchasing an additional 1,800,809 shares during the last quarter. ING Groep NV raised its holdings in shares of Darling Ingredients by 244.1% during the third quarter. ING Groep NV now owns 810,100 shares of the company’s stock valued at $30,103,000 after acquiring an additional 574,700 shares in the last quarter. Earnest Partners LLC raised its holdings in shares of Darling Ingredients by 14.0% during the second quarter. Earnest Partners LLC now owns 3,829,265 shares of the company’s stock valued at $140,725,000 after acquiring an additional 470,170 shares in the last quarter. Citigroup Inc. raised its holdings in shares of Darling Ingredients by 2,842.2% during the third quarter. Citigroup Inc. now owns 465,985 shares of the company’s stock valued at $17,316,000 after acquiring an additional 450,147 shares in the last quarter. Finally, Canada Pension Plan Investment Board bought a new position in shares of Darling Ingredients during the second quarter valued at approximately $15,406,000. Institutional investors own 94.44% of the company’s stock.
Darling Ingredients Trading Down 1.3 %
NYSE DAR opened at $40.56 on Thursday. Darling Ingredients Inc. has a 12 month low of $32.67 and a 12 month high of $51.36. The stock has a market cap of $6.45 billion, a P/E ratio of 25.04 and a beta of 1.23. The stock’s fifty day moving average price is $38.65 and its 200-day moving average price is $38.44. The company has a current ratio of 1.41, a quick ratio of 0.83 and a debt-to-equity ratio of 0.89.
Wall Street Analysts Forecast Growth
A number of equities analysts recently commented on DAR shares. Jefferies Financial Group upped their target price on Darling Ingredients from $44.00 to $46.00 and gave the company a “buy” rating in a report on Friday, October 25th. Piper Sandler reduced their price target on Darling Ingredients from $50.00 to $48.00 and set an “overweight” rating on the stock in a research note on Friday, October 11th. TD Cowen reduced their price target on Darling Ingredients from $45.00 to $43.00 and set a “hold” rating on the stock in a research note on Friday, September 13th. Finally, JPMorgan Chase & Co. upped their price target on Darling Ingredients from $58.00 to $59.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 30th. Two equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, Darling Ingredients has a consensus rating of “Moderate Buy” and a consensus target price of $53.44.
View Our Latest Stock Report on DAR
Darling Ingredients Profile
Darling Ingredients Inc develops, produces, and sells natural ingredients from edible and inedible bio-nutrients in North America, Europe, China, South America, and internationally. The company operates through three segments: Feed Ingredients, Food Ingredients, and Fuel Ingredients. It offers ingredients and customized specialty solutions for customers in the pharmaceutical, food, pet food, feed, industrial, fuel, bioenergy, and fertilizer industries.
Featured Articles
- Five stocks we like better than Darling Ingredients
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Golden Cross Stocks: Pattern, Examples and Charts
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Compound Interest and Why It Matters When Investing
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Darling Ingredients Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Darling Ingredients and related companies with MarketBeat.com's FREE daily email newsletter.